Biography Antibody engineering and multi-specific antibody (drug conjugate) development for cancer therapy Role Postdoc Category Research Education PhD, 06/2023 - Biology, Tsinghua UniversityMS, 08/2017 - Pharmaceutical biotechnology, Wageningen University & Research07/2017 - Glycoscience, National Institute for Bioprocessing Research and TrainingBS, 06/2014 - Biotechnology, China Agricultural University Publications Quantifying Protein Shape to Elucidate Its Influence on Solution Viscosity in High-Concentration Electrolyte Solutions. Tian Z, Jiang X, Chen Z, Huang C, Qian F Molecular pharmaceutics . Feb 27, 2024 A bioengineered anti-VEGF protein with high affinity and high concentration for intravitreal treatment of wet age-related macular degeneration. Huang C, Wang Y, Huang J, Liu H, Chen Z, Jiang Y, Chen Y, Qian F Bioengineering & translational medicine . Dec 19, 2023 Polymorphic nanobody crystals as long-acting intravitreal therapy for wet age-related macular degeneration. Zhu S, Fan S, Tang T, Huang J, Zhou H, Huang C, Chen Y, Qian F Bioengineering & translational medicine . May 4, 2023 Multivalent nanobodies with rationally optimized linker and valency for intravitreal VEGF neutralization Huang C, Huang J, Zhu S, Tang T, Chen Y, Qian F Chemical Engineering Science . Apr 15, 2023 Spray-Dried Monoclonal Antibody Suspension for High-Concentration and Low-Viscosity Subcutaneous Injection. Huang C, Chen L, Franzen L, Anderski J, Qian F Molecular pharmaceutics . Apr 13, 2022 Hypoxia Alters Epigenetic and N-Glycosylation Profiles of Ovarian and Breast Cancer Cell Lines in-vitro. Greville G, Llop E, Huang C, Creagh-Flynn J, Pfister S, O'Flaherty R, Madden SF, Peracaula R, Rudd PM, McCann A, Saldova R Frontiers in oncology . Jul 29, 2020
